The efficacy and safety of irinotecan hydrochloride liposome injection (II) combined with apatinib mesylate tablets in the second-line treatment of locally advanced or metastatic HER-2 negative gastric or gastroesophageal junction adenocarcinoma: A single-arm, prospective, exploratory clinical study

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 6e3a495e0c60f710466e015b549d643061d5d513
First added on: Oct 10, 2026